Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
79 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince Charles Hospital
Chermside, Queensland, Australia
- Core Research Group Pty. Ltd.
Milton, Queensland, Australia
- Austrials
Taringa, Queensland, Australia
- University of Tasmania at Hobart
Hobart, Tasmania, Australia
- Barwon Health-University Hospital Geelong
Geelong, Victoria, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia
- C-Endo - Endocrinology Centre
Calgary, Alberta, Canada
- Bc Diabetes
Vancouver, British Columbia, Canada
- Lmc Diabetes & Endocrinology Ltd. - Brampton
Brampton, Ontario, Canada
- Lmc Diabetes & Endocrinology Ltd. - Thornhill
Concord, Ontario, Canada
- Lmc Diabetes & Endocrinology Ltd. - Etobicoke
Etobicoke, Ontario, Canada
- Centre for Studies in Family Medicine, Western Centre for Public Health and Family Medicine, Western University
London, Ontario, Canada
- Lmc Diabetes & Endocrinology Ltd. - Toronto
Toronto, Ontario, Canada
- Ecogene-21
Chicoutimi, Quebec, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Quebec
Québec, Quebec, Canada
- Edumed S.R.O.
Jaroměř, Czechia
- Nemocnice Pardubickeho Kraje, A.S., Nemocnice Pardubice
Pardubice, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Hôpital Jean-Verdier - Ap-Hp; Service Endocrinologie Diabétologie Nutrition
Bondy, France
- Chu Henri Mondor
Créteil, France
- Chu de Nantes, Clinique D'Endocrinologie
Nantes, France
- Centre Hospitalier de Valenciennes
Valenciennes, France
- Klinikum Frankfurt (oder) Gmbh
Frankfurt (Oder), Brandenburg, Germany
- Herz-Und Diabeteszentrum Nrw Universitaetsklinik Der Ruhr-Universitaet Bochum
Bad Oeynhausen, North Rhine-Westphalia, Germany
- Cardiologicum Pirna Und Dresden
Dresden, Saxony, Germany
- Klinische Forschung Berlin Gbr
Berlin, Germany
- Zks - Zentrum Klinische Studien Sudbrandenburg Gmbh
Elsterwerda, Germany
- Erik Yee Mun George Fung
Shatin, Hong Kong
- Prince of Wales Hospital; Chinese University of Hong Kong; Dept of Medicine and Therapeutics
Shatin, Hong Kong
- Centrum Chorob Serca W Usk
Wroclaw, Borowska, Poland
- Nzoz Specjalistyczny Osrodek Internistyczno - Diabetologiczny
Bialystok, Poland
- Centrum Twojego Zdrowia
Krakow, Poland
- Topolowa Medicenter Mrózek & Wspólnicy Sp.J.
Krakow, Poland
- Etg Lodz
Lodz, Poland
- Praktyka Lekarska Ewa Krzyzagorska
Poznan, Poland
- Prywatny Gabinet Lekarski Centrum Medyczne Diabetika
Radom, Poland
- Centrum Medyczne Medyk Stanislaw Mazur Sp. Z O.O. Sk
Rzeszów, Poland
- 4 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zoz We Wroclawiu
Wroclaw, Poland
- Hospital Germans Trias I Pujol
Badalona, Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Sept 2019
- Primary completion
- 31 Dec 2023
- Completion
- 31 Dec 2025
- Last update posted
- 8 Dec 2022
- Registered enrollment
- 675
- Registry id
- NCT04083339
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.